KARAKIEWICZ, P. I.; ZAFFUTO, E.; KAPOOR, A.; BASAPPA, N. S.; BJARNASON, G. A.; BLAIS, N.; BREAU, R. H.; CANIL, C.; DRACHENBERG, D.; HOTTE, S. J.; JELDRES, C.; JEWETT, M. A.; KASSOUF, W.; KOLLMANNSBERGER, C.; LAVALLÉE, L. T.; MALONI, R.; PATENAUDE, F.; POULIOT, F.; REAUME, M. N.; SABBAGH, R.; SHAYEGAN, B.; SO, A.; SOULIÈRES, D.; TANGUAY, S.; WOOD, L.; BANDINI, M. Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Canadian Urological Association Journal, [S. l.], v. 12, n. 6, p. 173–80, 2018. DOI: 10.5489/cuaj.5187. Disponível em: https://cuaj.ca/index.php/journal/article/view/5187. Acesso em: 25 apr. 2024.